Health
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – The Korea Herald
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory…
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in Indonesia and Philippines for Novavax’ recombinant nanoparticle COVID-19 vaccine
– Filing for World Health Organization…
-
Noosa News22 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General15 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News16 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
Noosa News23 hours agoFrank Moneger identified as man accused of hit-and-run death of 17-year-old girl in Margate, Queensland